Recruiting OBSERVATIONAL NCT05505500

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. (Prepare-NS)

Preparing a Clinical Outcomes Assessment Set for Nephrotic Syndrome

Sponsor: Food and Drug Administration (FDA)

Conditions Edema FSGS Fluid Overload Glomerular Disease Glomerulosclerosis, Focal Segmental IgM Nephropathy Membranous Nephropathy Minimal Change Disease Minimal Change Nephrotic Syndrome Nephrotic Syndrome Nephrotic Syndrome With Edema (Diagnosis) Nephrotic Syndrome in Children Nephrotic Syndrome, Minimal Change

Interventions Interview

Updated 7 times since 2022 Last updated: Dec 15, 2025 Started: Apr 18, 2022 Primary completion: Apr 30, 2026 Completion: Apr 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05505500, this observational or N/A phase trial focuses on Edema and FSGS and remains actively recruiting participants. Sponsored by Food and Drug Administration (FDA), it has been updated 7 times since 2022, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Recruiting
Nov 2024 — Jan 2026 [monthly]

Recruiting
Sep 2024 — Nov 2024 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Oct 2023 — Jul 2024 [monthly]

Recruiting

▶ Show 2 earlier versions

May 2023 — Oct 2023 [monthly]

Recruiting
Sep 2022 — May 2023 [monthly]

Recruiting

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Food and Drug Administration (FDA)
Northwestern University
University of Michigan

Data source: University of Michigan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ann Arbor, United States